產學研發-EN

Title: NHRI technology, “DBPR211: a peripheral CB1 rece …

Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR211: a peripheral CB1 receptor antagonist”（2018/12/17） Read More »

Title: NHRI technology, “DBPR114: a multi-targeted kina …

Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR114: a multi-targeted kinase inhibitor for solid tumors”（2018/12/13） Read More »